HomeBIO • NYSE
Bio-Rad Laboratories, Inc. Class A Common Stock
$351.70
After Hours:
$351.70
(0.00%)0.00
Closed: Jan 13, 5:05:00 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$341.75
Day range
$342.34 - $352.80
Year range
$262.12 - $387.99
Market cap
9.84B USD
Avg Volume
161.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
CDP Climate Change Score
D-
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
649.73M2.79%
Operating expense
291.34M19.14%
Net income
653.17M514.71%
Net profit margin
100.53498.04%
Earnings per share
2.01-13.73%
EBITDA
103.47M-19.45%
Effective tax rate
24.19%—
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
1.62B-7.76%
Total assets
10.60B-10.86%
Total liabilities
3.12B-10.46%
Total equity
7.49B—
Shares outstanding
28.00M—
Price to book
1.28—
Return on assets
1.59%—
Return on capital
1.89%—
Net change in cash
(USD)Sep 2024Y/Y change
Net income
653.17M514.71%
Cash from operations
163.56M67.39%
Cash from investing
-55.64M-485.64%
Cash from financing
-95.99M-260.88%
Net change in cash
4.47M-93.41%
Free cash flow
23.87M-46.32%
About
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide. Wikipedia
Founded
1952
Employees
8,030
Search
Clear search
Close search
Google apps
Main menu